• 34 Hits
  • Search Condition : Filter (MeSH = CD8-Positive T-Lymphocytes / immunology*)
Species Resource Title
Human and Animal Cells Colon-26(RCB2657) Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
Human and Animal Cells BALL-1(RCB0256) PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Mice RBRC04895 Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity.
Human and Animal Cells OV2944-HM-1(RCB1483) B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Human and Animal Cells B16 melanoma/lacZ(RCB1284) Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells.
General Microbes JCM6515 , JCM31915 CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes.
Human and Animal Cells 293T(RCB2202) Microfluidics sorting enables the isolation of an intact cellular pair complex of CD8+ T cells and antigen-presenting cells in a cognate antigen recognition-dependent manner.
Human and Animal Cells MKN45(RCB1001) STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells.
Human and Animal Cells NIH3T3 Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells.
Human and Animal Cells MBT-2(RCB0544) , 293T(RCB2202) Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2).
Human and Animal Cells 293T(RCB2202) Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN.
Mice RBRC01420 Chronic virus infection drives CD8 T cell-mediated thymic destruction and impaired negative selection.
Human and Animal Cells HEV0060 , PC-9(RCB4455) Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Mice RBRC00916 , RBRC10034 A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.
Human and Animal Cells HLC-1(RCB0083) Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Mice RBRC01834 KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity.
DNA material pCAmGCSF (RDB01522) , pCAZ 2 (RDB01870). PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo.
Mice RBRC00753 Sema4D is required in both the adaptive and innate immune responses of contact hypersensitivity.
Human and Animal Cells T2(RCB1932) Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients.
Human and Animal Cells TE-1(RCB1894) , Colon-26(RCB2657) Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.